Neurological diseases are the foremost cause of ill health and disability worldwide. Open Access Government offers an overview of the prevalence of these conditions.
Dr Gerry Morrow shares his thoughts on the current state of play when it comes to the early diagnosis of neurodegenerative disorders, and asks the questions, can we screen, and should we screen?
A new study published in the Movement Disorders journal, has paved the way for more research into identifying markers of progression for patients in the early stages of Parkinson’s disease
National Institutes of Health scientists develop new brain disease test for the early diagnosis of Parkinson’s disease and dementia with Lewy bodies
The group, led...
Table Tennis Scotland awarded £45,000 to become dementia friendly
Table Tennis Scotland is receiving £35,000 from the Life Changes Trust and £10,000 from Sportscotland to become...
The European Parkinson’s Disease Association (EPDA) provide an update about the positive progress being made for people with Parkinson’s
My PD Journey is a multi-stakeholder...
Writing on behalf of the Chartered Society of Physiotherapy, Dr. Bhanu Ramaswamy highlights how physiotherapy can help manage the symptoms of Parkinson’s
The changing pharma landscape means opportunities for Parkinson's drug discovery are missed, but Parkinson's UK has a new strategy to redress the balance
This will...
UCB's Duncan McHale outlines why reclassification might be a good idea to boost drug development for neurodegenerative diseases like Alzheimer's and Parkinson's
Neurodegenerative diseases are...
Claire Bale, Communications Manager for Parkinson’s UK, highlights the latest thinking in stem cell research for the potential treatment of Parkinson’s.
Stem cells can develop...
Advertisements
Latest Academic Articles
The latest academic articles from key research stakeholders
